Elin H. Kure

11.3k total citations
80 papers, 2.5k citations indexed

About

Elin H. Kure is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Elin H. Kure has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 33 papers in Cancer Research and 31 papers in Molecular Biology. Recurrent topics in Elin H. Kure's work include Genetic factors in colorectal cancer (17 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Colorectal Cancer Treatments and Studies (12 papers). Elin H. Kure is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), Pancreatic and Hepatic Oncology Research (15 papers) and Colorectal Cancer Treatments and Studies (12 papers). Elin H. Kure collaborates with scholars based in Norway, Denmark and Sweden. Elin H. Kure's co-authors include Tone Ikdahl, Mona Sæbø, Tormod Kyrre Guren, Julian Hamfjord, Kjell M. Tveit, Ulla Vogel, Camilla Furu Skjelbred, Aage Haugen, Inger Marie Bowitz Lothe and David Ryberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Elin H. Kure

78 papers receiving 2.5k citations

Peers

Countries citing papers authored by Elin H. Kure

Since Specialization

Citations

This map shows the geographic impact of Elin H. Kure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elin H. Kure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elin H. Kure more than expected).

Fields of papers citing papers by Elin H. Kure

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elin H. Kure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elin H. Kure. The network helps show where Elin H. Kure may publish in the future.

Co-authorship network of co-authors of Elin H. Kure

This figure shows the co-authorship network connecting the top 25 collaborators of Elin H. Kure. A scholar is included among the top collaborators of Elin H. Kure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elin H. Kure. Elin H. Kure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indole 3-acetate and response to therapy in borderline resectable or locally advanced pancreatic cancer 2024 ·Frontiers in Oncology ·(unknown), (unknown), Elin H. Kure, Sheraz Yaqub, Adrian McCann, Per Magne Ueland, Knut Jørgen Labori, Johannes R. Hov	2
2	Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends 2024 ·SHILAP Revista de lepidopterología ·(unknown), Tor Åge Myklebust, (unknown), Inger Kristin Larsen, Tormod Kyrre Guren, Elin H. Kure, Kjell M. Tveit, Bengt Glimelius, Marianne G. Guren, Julian Hamfjord	2
3	Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome 2022 ·Cancer Research Communications ·Laxmi Silwal‐Pandit, (unknown), Henrik J. Johansson, Georgios Mermelekas, Inger Marie Bowitz Lothe, Martina L. Skrede, (unknown), Daniel Nebdal, Åslaug Helland, Ole Christian Lingjærde, Knut Jørgen Labori, Bjørn Steen Skålhegg, Janne Lehtiö, Elin H. Kure	5
4	Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma 2022 ·Frontiers in Oncology ·(unknown), Vilde Drageset Haakensen, Laxmi Silwal‐Pandit, Julian Hamfjord, Patrick Micke, Johan Botling, Odd Terje Brustugun, Ole Christian Lingjærde, Åslaug Helland, Elin H. Kure	3
5	Meta-Analysis of 1,200 Transcriptomic Profiles Identifies a Prognostic Model for Pancreatic Ductal Adenocarcinoma 2019 ·JCO Clinical Cancer Informatics ·Vandana Sandhu, Knut Jørgen Labori, Ayelet Borgida, Ilinca M. Lungu, John M.S. Bartlett, Sara Hafezi‐Bakhtiari, Robert E. Denroche, Gun Ho Jang, Danielle Pasternack, (unknown), (unknown), Julie M. Wilson, Elin H. Kure, Steven Gallinger, Benjamin Haibe‐Kains	7
6	Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy 2019 ·Annals of Oncology ·Julian Hamfjord, Tormod Kyrre Guren, Olav Dajani, Julia S. Johansen, Bengt Glimelius, Halfdan Sørbye, Per Pfeiffer, Ole Christian Lingjærde, Kjell M. Tveit, Elin H. Kure, Niels Pallisgaard, K.-L.G. Spindler	57
7	Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome 2018 ·British Journal of Cancer ·(unknown), Eva Skovlund, Halfdan Sørbye, Nils Bolstad, Kjell Nustad, Bengt Glimelius, Per Pfeiffer, Elin H. Kure, Julia S. Johansen, Kjell Magne Tveit, Thoralf Christoffersen, Tormod Kyrre Guren	51
8	Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study 2017 ·British Journal of Cancer ·Tormod Kyrre Guren, (unknown), Elin H. Kure, Halfdan Sørbye, Bengt Glimelius, Per Pfeiffer, Pia Österlund, Fridbjörn Sigurdsson, Inger Marie Bowitz Lothe, (unknown), Eva Skovlund, Thoralf Christoffersen, Kjell Magne Tveit	51
9	The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma 2016 ·Cancer Research ·Vandana Sandhu, David C. Wedge, Inger Marie Bowitz Lothe, Knut Jørgen Labori, Stefan C. Dentro, Trond Buanes, Martina L. Skrede, (unknown), Else Munthe, Ola Myklebost, Ole Christian Lingjærde, Anne‐Lise Børresen‐Dale, Tone Ikdahl, Peter Van Loo, Silje Nord, Elin H. Kure	27
10	AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin 2015 ·The Pharmacogenomics Journal ·(unknown), (unknown), Tormod Kyrre Guren, Julian Hamfjord, Göran Carlsson, Bengt Gustavsson, Tone Ikdahl, (unknown), Per Pfeiffer, Ole Christian Lingjærde, Kjell M. Tveit, Yvonne Wettergren, Elin H. Kure	18
11	Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma 2015 ·Molecular Oncology ·(unknown), Inger Marie Bowitz Lothe, Knut Jørgen Labori, (unknown), Julian Hamfjord, (unknown), Trond Buanes, (unknown), Mohan Kale, (unknown), Urmila Kulkarni‐Kale, A.L. Børresen-Dale, Ole Christian Lingjærde, Elin H. Kure	15
12	Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis 2014 ·PLoS ONE ·Lotte K. Vogel, Mona Sæbø, Helle Høyer, Tine Iskov Kopp, Ulla Vogel, Sine Godiksen, (unknown), Julian Hamfjord, (unknown), Egil Johnson, Elin H. Kure, Vibeke Andersen	34
13	Correction: Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis 2013 ·PLoS ONE ·Vibeke Andersen, Ulla Vogel, Sine Godiksen, (unknown), (unknown), Julian Hamfjord, Elin H. Kure, Lotte K. Vogel	9
14	Wobble-enhanced ARMS Method for Detection of KRAS and BRAF Mutations 2011 ·Diagnostic Molecular Pathology ·Julian Hamfjord, (unknown), Martina L. Skrede, Kjell M. Tveit, Tone Ikdahl, Elin H. Kure	16
15	Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes 2010 ·Carcinogenesis ·Camilla Furu Skjelbred, Martin Veel Svendsen, (unknown), (unknown), (unknown), Elin H. Kure, Jarno Tuimala, Hannu Norppa, (unknown)	16
16	Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma 2007 ·BMC Cancer ·(unknown), Lotte K. Vogel, Rikke Lewinsky, Mona Sæbø, Camilla Furu Skjelbred, Sine Godiksen, Geir Hoff, Kjell M. Tveit, Inger Marie Bowitz Lothe, Tone Ikdahl, Elin H. Kure, Cathy Mitchelmore	65
17	The ratio of Matriptase/HAI-1mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals 2006 ·BMC Cancer ·Lotte K. Vogel, Mona Sæbø, Camilla Furu Skjelbred, Kathrine Abell, Esben Pedersen, Ulla Vogel, Elin H. Kure	61
18	Polymorphisms of the XRCC1, XRCC3 and XPDgenes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study 2006 ·BMC Cancer ·Camilla Furu Skjelbred, Mona Sæbø, Håkan Wallin, Bjørn A. Nexø, (unknown), Inger Marie Bowitz Lothe, Steinar Aase, Egil Johnson, Inger‐Lise Hansteen, Ulla Vogel, Elin H. Kure	99
19	Genetic susceptibility and environmental estrogen-like compounds 2001 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Vessela N. Kristensen, Elin H. Kure, Björn Erikstein, Nobuhiro Harada, Anne‐Lise Børresen‐Dale	15
20	Biological monitoring of polycyclic aromatic hydrocarbon exposure in a highly polluted area of Poland 1995 ·Environmental Health Perspectives ·Steinar Øvrebø, (unknown), Ewa Grzybowska, Elin H. Kure, M Choraźy, Aage Haugen	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact